Año: 2022
Journal Impact Factor (JIF): 8.20
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
ENDOCRINOLOGY & METABOLISM | SCIE | 13/145 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 1,830
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
ENDOCRINOLOGY & METABOLISM | 10/184 | Q1 | T1 | D1 | 94,84 |
Año:
2022
CiteScore:
17,600
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Endocrinology, Diabetes and Metabolism | 10/232 | Q1 | T1 | D1 |
Internal Medicine | 7/140 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
3,349
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Endocrinology, Diabetes and Metabolism | 6/245 | Q1 | T1 | D1 |
Internal Medicine | 7/163 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
European Union's Horizon 2020 research and innovation programme via the Innovative Medicines Initiative 2 Joint Undertaking | 115881 |
MRC | MR/R022259/1; MR/P023223/1; MR/R022259/1; MR/P023223/1 |
Novo Nordisk Foundation | NNF18CC0034900 |
Wellcome Trust | WT212625/Z/18/Z |
# | Autor | Afiliación |
---|---|---|
1 | Nguyen-Tu, MS | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
2 | Harris, J | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
3 | Martinez-Sanchez, A | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
4 | Chabosseau, P | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
5 | Hu, M | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
6 | Georgiadou, E | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
7 | Pollard, A | MRC London Institute of Medical Sciences; AstraZeneca (England) |
8 | Otero, P | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
9 | Lopez-Noriega, L | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
10 | Leclerc, I | Imperial College London Division of Diabetes Endocrinology and Metabolism (England) |
11 | Sakamoto, K | Novo Nordisk Ctr Basic Metab Res (Denmark) |
12 | Schmoll, D | Sanofi-Aventis (Germany) |
13 | Smith, DM | AstraZeneca (England) |
14 | Carling, D | MRC London Institute of Medical Sciences (England) |
15 | Lee Kong Chian School of Medicine; Imperial College London Division of Diabetes Endocrinology and Metabolism; Centre Hospitalier de l'Universite de Montreal Centre de Recherche (Singapore) |